Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Language
Publication year range
1.
Lett Appl Microbiol ; 73(3): 270-279, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34146437

ABSTRACT

Antimicrobial resistance is widely studied and well-characterized from a clinical perspective. However, considerably less information is available regarding resistance in environmental settings, especially in aquatic habitats. This study presents data regarding the occurrence, distribution and the antimicrobial susceptibility profile of bacteria isolated from Guanabara Bay (GB), a heavily polluted tropical urban estuary and an important tourist attraction in Rio de Janeiro, Brazil. Water samples from sites characterized by growing degrees of pollution were analysed by culture-dependent methods, revealing the presence of multidrug-resistant bacteria and clinically relevant indicators of antimicrobial resistance, such as extended-spectrum beta-lactamases. Isolates were identified by mass spectrometry, which indicated the presence of potential human pathogens such as Aeromonas spp. and Vibrio spp. Bacteria harbouring beta-lactam resistance genes were also detected. Although GB is widely used as a recreational and fishing area, there is a substantial knowledge gap regarding the monitoring of antimicrobial resistance and the risk that exposure to these waters poses to public health. Thus, this study reveals new information that calls for better comprehension of antimicrobial resistance in aquatic environments, especially those used for recreational purposes.


Subject(s)
Anti-Bacterial Agents , beta-Lactamases , Anti-Bacterial Agents/pharmacology , Brazil , Drug Resistance, Bacterial , Estuaries , Humans , Microbial Sensitivity Tests , beta-Lactamases/genetics
2.
J Appl Microbiol ; 131(2): 706-718, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33421270

ABSTRACT

AIMS: Evaluation of the antibacterial activity of cultivable bacteria associated with the marine sponges Hymeniacidon perlevis and Halichondria panicea against multi-drug-resistant Staphylococcus aureus. METHODS AND RESULTS: One hundred and fourteen bacterial isolates were recovered from H. perlevis and H. panicea. Antibacterial action was demonstrated by 70% of the isolates against reference strain Staphylococcus aureus ATCC 29213 and by 31·6% against Pseudomonas aeruginosa ATCC 27853 in agar overlay assays. Antibacterial potential was further analysed against 36 multi-drug-resistant hospital Staphylococcus aureus strains with diverse resistance profiles. Among the 80 isolates positive against S. aureus ATCC 29213, 76·3% were active against at least one clinical S. aureus pathogen and 73·6% inhibited one or more methicillin-resistant (MRSA) and vancomycin non-susceptible S. aureus strains. In addition, 41·3% inhibited all vancomycin nonsusceptible MRSA strains. CONCLUSIONS: Culturable bacteria associated to H. perlevis and H. panicea are promising sources of antibacterial compounds of great pharmaceutical interest. SIGNIFICANCE AND IMPACT OF THE STUDY: This study was the first to explore the antibacterial potential of culturable bacteria associated with the marine sponges H. perlevis and H. panicea against MDR bacteria. This is the first report of antibacterial activity by Aquimarina, Denitrobaculum, Maribacter and Vagococcus isolates against MDR S. aureus strains, including vancomycin nonsusceptible and methicillin-resistant ones, against which new antibiotics are urgently needed.


Subject(s)
Anti-Bacterial Agents/pharmacology , Methicillin-Resistant Staphylococcus aureus/drug effects , Porifera/microbiology , Animals , Anti-Bacterial Agents/biosynthesis , Bacteria/metabolism , Methicillin Resistance/drug effects , Pseudomonas aeruginosa/drug effects , Staphylococcus aureus/drug effects , Vancomycin/pharmacology
3.
Arq. bras. med. vet. zootec. (Online) ; 69(6): 1669-1675, nov.-dez. 2017. graf
Article in English | LILACS, VETINDEX | ID: biblio-911299

ABSTRACT

Mastitis is an inflammation of the mammary gland that affects dairy cattle worldwide causing economic losses. Coagulase-negative staphylococci (CNS) are the predominant cause of this type of infection. We have recently showed that coagulase-positive staphylococci could be misidentified. So, the aim of this study was to characterize the Staphylococcus spp. strains initially classified as coagulase-negative Staphylococci, isolated from buffalo with subclinical mastitis. Milk of buffaloes with mastitis in herds was collected and 9 strains were identified as CNS by phenotypic tests. Molecular methodologies latter identified the strains as coagulase-negative Staphylococcus chromogenes (5), coagulase-positive Staphylococcus hyicus (2) and coagulase-positive Staphylococcus aureus (2). Our results strongly support the need to identify the isolates to a species level in order to avoid misidentification and to be aware of the classification using the coagulase test alone.(AU)


A mastite é uma inflamação da glândula mamária que afeta o gado leiteiro em todo o mundo, causando perdas econômicas. Staphylococcus coagulase-negativa (SCN) são a causa predominante desse tipo de infecção. Mostrou-se recentemente que Staphylococcus coagulase-positiva podem ser identificados erroneamente. Assim, o objetivo deste estudo foi caracterizar cepas de Staphylococcus spp. inicialmente classificados como Staphylococcus coagulase-negativa, isolados de búfalas com mastite subclínica. O leite de búfalas com mastite foi coletado, e nove cepas foram identificadas como SCN por testes fenotípicos. Metodologias moleculares identificaram as cepas como Staphylococcus chromogenes coagulase-negativa (5) Staphylococcus hyicus coagulase-positiva (2) e Staphylococcus aureus coagulase-positiva (2). Os resultados reforçam a necessidade de identificar as cepas em termos de espécie, a fim de se evitarem erros de identificação e estar atento à classificação utilizando o teste de coagulase sozinho.(AU)


Subject(s)
Animals , Staphylococcus/isolation & purification , Buffaloes/microbiology , Milk/microbiology , Coagulase/analysis , Mastitis/veterinary
4.
Lett Appl Microbiol ; 63(3): 215-21, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27377762

ABSTRACT

UNLABELLED: Staphylococcus haemolyticus is an opportunistic human pathogen that usually gains entry into the host tissue in association with medical device contamination. Biofilm formation is a key factor for the establishment of this bacterium and its arrangement and dynamics can be influenced by the synthesis of biosurfactants. Biosurfactants are structurally diverse amphiphilic molecules with versatile biotechnological applications, but information on their production by staphylococci is still scarce. In this work, two Staph. haemolyticus strains, showing high potential for biosurfactant production - as observed by four complementary methods - were investigated. Biosurfactant extracts were produced and studied for their capacity to inhibit the growth and biofilm formation by other bacterial human pathogens. The biosurfactant produced by the one of the strains inhibited the growth of most bacteria tested and subinhibitory concentrations of the biosurfactant were able to decrease biofilm formation and showed synergistic effects with tetracycline. Because these results were also positive when the biosurfactants were tested against the producing strains, it is likely that biosurfactant production by Staph. haemolyticus may be an unexplored virulence factor, important for competition and biofilm formation by the bacterium, in addition to the biotechnological potential. SIGNIFICANCE AND IMPACT OF THE STUDY: This work is the first to show the production of biosurfactants by Staphylococcus haemolyticus strains. Extracts showed antimicrobial, anti-adhesive and synergistic properties against a variety of relevant human pathogens, including the producing strains. In addition to the biotechnological potential, biosurfactants produced by Staph. haemolyticus are potentially undescribed virulence determinants in their producing strains.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Adhesion/drug effects , Biofilms/growth & development , Staphylococcus haemolyticus/metabolism , Staphylococcus haemolyticus/pathogenicity , Surface-Active Agents/pharmacology , Anti-Bacterial Agents/metabolism , Bacterial Adhesion/physiology , Biofilms/drug effects , Humans , Microbial Sensitivity Tests , Surface-Active Agents/metabolism
5.
Lett Appl Microbiol ; 60(2): 140-147, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25355062

ABSTRACT

Marine bacteria are a rich source of structurally unique natural compounds, several of which have shown a wide variety of biological activities. In this study, the metabolites present in the culture supernatants of the eight sponge-associated bacteria were extracted using ethyl acetate, and all extracts showed activity against Staphylococcus aureus. Subsequently, the extracts of the Pseudomonas fluorescens H40 and H41, and Pseudomonas aeruginosa H51 were subjected to solvent partitioning, and the active fractions were submitted to chromatographic separation. Three different active fractions were obtained, one of which was identified as diketopiperazine cyclo-(L-Leu-L-Pro). This substance was bactericidal for Staph. aureus and Ps. aeruginosa and showed cytotoxic activity against HEp-2 tumour cells. Putative gene fragments coding for the type I polyketide synthase (PKS-I) and nonribosomal peptide synthetase (NRPS) domains were PCR-amplified from five and three strains, respectively. The results suggest that sponge-associated bacteria analysed in this study may represent a potential source for production of antimicrobial substances against bacterial pathogens of medical importance.


Subject(s)
Anti-Bacterial Agents/biosynthesis , Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Bacteria/metabolism , Porifera/microbiology , Animals , Anti-Bacterial Agents/chemistry , Antibiosis , Bacteria/genetics , Bacteria/isolation & purification , Biotechnology , Brazil , Cell Line, Tumor , Diketopiperazines/metabolism , Microbial Sensitivity Tests , Peptide Synthases/genetics , Polyketide Synthases/genetics , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/isolation & purification , Pseudomonas aeruginosa/metabolism , Pseudomonas fluorescens/isolation & purification , Pseudomonas fluorescens/metabolism , Staphylococcus aureus/drug effects
6.
Eur J Clin Microbiol Infect Dis ; 33(1): 29-33, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23887612

ABSTRACT

The purpose of this study was to determine the reliability of the MicroScan WalkAway PosCombo21 (PC21) system for the identification of coagulase-negative staphylococci (CNS) strains and the detection of oxacillin resistance. Using molecular and phenotypic methods, 196 clinical strains were evaluated. The automated system demonstrated 100 % reliability for the identification of the clinical strains Staphylococcus haemolyticus, Staphylococcus hominis and Staphylococcus cohnii; 98.03 % reliability for the identification of Staphylococcus epidermidis; 70 % reliability for the identification of Staphylococcus lugdunensis; 40 % reliability for the identification of Staphylococcus warneri; and 28.57 % reliability for the identification of Staphylococcus capitis, but no reliability for the identification of Staphylococcus auricularis, Staphylococcus simulans and Staphylococcus xylosus. We concluded that the automated system provides accurate results for the more common CNS species but often fails to accurately identify less prevalent species. For the detection of oxacillin resistance, the automated system showed 100 % specificity and 90.22 % sensitivity. Thus, the PC21 panel detects oxacillin-resistant strains, but is limited by the heteroresistance that is observed when using most phenotypic methods.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteriological Techniques/methods , Coagulase/metabolism , Oxacillin/pharmacology , Staphylococcal Infections/diagnosis , Staphylococcus/isolation & purification , beta-Lactam Resistance , Humans , Sensitivity and Specificity , Staphylococcal Infections/microbiology , Staphylococcus/drug effects , Staphylococcus/enzymology
7.
Curr Pharm Biotechnol ; 10(1): 86-105, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19149592

ABSTRACT

Sponges (phylum Porifera) are sessile marine filter feeders that have developed efficient defense mechanisms against foreign attackers such as viruses, bacteria, or eukaryotic organisms. Marine sponges are among the richest sources of pharmacologically-active chemicals from marine organisms. It is suggested that (at least) some of the bioactive secondary metabolites isolated from sponges are produced by functional enzyme clusters, which originated from the sponges and their associated microorganisms. More than 5,300 different products are known from sponges and their associated microorganisms, and more than 200 new metabolites from sponges are reported each year. As infectious microorganisms evolve and develop resistance to existing pharmaceuticals, the marine sponge provides novel leads against bacterial, viral, fungal and parasitic diseases. Many marine natural products have successfully advanced to the late stages of clinical trials, as for example ara-A (vidarabine), an anti-viral drug used against the herpes simplex encephalitis virus. This substance is in clinical use for many years. Moreover, a growing number of candidates have been selected as promising leads for extended preclinical assessment, including manzamine A (activity against malaria, tuberculosis, HIV, and others), lasonolides (antifungal activity) and psammaplin A (antibacterial activity). In this review we have surveyed the discoveries of products derived from marine sponges and associated bacteria that have shown in vivo efficacy or potent in vitro activity against infectious and parasitic diseases, including bacterial, viral, fungal and protozoan infections. Our objective was to highlight the substances that have the greatest potential to lead to clinically useful treatments.


Subject(s)
Anti-Infective Agents/classification , Porifera/chemistry , Animals , Anti-Bacterial Agents/classification , Anti-Bacterial Agents/isolation & purification , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/isolation & purification , Anti-Infective Agents/therapeutic use , Antifungal Agents/classification , Antifungal Agents/isolation & purification , Antifungal Agents/therapeutic use , Antiprotozoal Agents/classification , Antiprotozoal Agents/isolation & purification , Antiprotozoal Agents/therapeutic use , Antiviral Agents/classification , Antiviral Agents/isolation & purification , Antiviral Agents/therapeutic use , Humans , Porifera/microbiology , Porifera/physiology
8.
Curr Microbiol ; 42(4): 264-8, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11178727

ABSTRACT

One of the outstanding problems in the field of heat shock response has been to elucidate the mechanism underlying the induction of heat shock proteins (HSPs). In this work, we initiate an analysis of the expression of heat shock groEL and dnaK genes and their promoters in S. pyogenes. The synthesis of total cellular proteins was studied upon transfer of a log-phase culture from 37 degrees C to 42 degrees C by performing 5-min pulse-labeling experiments with (35)S-Met. The heat shock responses in the pathogenic Gram-positive cocci, Enterococcus faecalis and Staphylococcus aureus, were also analyzed.


Subject(s)
Bacterial Proteins/biosynthesis , Chaperonin 60/genetics , Enterococcus faecalis/genetics , Escherichia coli Proteins , Gene Expression Regulation, Bacterial , HSP70 Heat-Shock Proteins/genetics , Staphylococcus aureus/genetics , Streptococcus pyogenes/genetics , Bacterial Proteins/genetics , Base Sequence , Blotting, Western , Chaperonin 60/biosynthesis , Electrophoresis, Polyacrylamide Gel , Enterococcus faecalis/metabolism , Enterococcus faecalis/physiology , HSP70 Heat-Shock Proteins/biosynthesis , Heat-Shock Response/genetics , Molecular Sequence Data , Promoter Regions, Genetic , Staphylococcus aureus/metabolism , Staphylococcus aureus/physiology , Streptococcus pyogenes/metabolism , Streptococcus pyogenes/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...